# Axis B: Neuro-Immunology & Glia Heterogeneity (ç¥ç»å…ç–«ä¸èƒ¶è´¨ç»†èƒå¼‚è´¨æ€§)
*Focus: Microglia states, neuroinflammation, and peripheral-central immune crosstalk.*

---

## 1. ç¥ç»å…ç–«äº¤äº’ä½œç”¨å›¾ (Neuro-Immune Interaction)

```text
   [ Peripheral Blood ]             ||             [ CNS / Brain ]
                                    ||
   ( T-cells / Myeloid ) â”€â”€â”€ğŸšªâ”€â”€â–¶ï¸  ||  â”€â”€â”€ğŸ’¥â”€â”€â”€> [ DAM Microglia ]
          Patrol                    ||             (Activated)
                                    ||                 â”‚
   [ Gut Microbiome ]               ||                 â”‚
          â”‚                         ||         [ Neuroinflammation ]
          â””â”€â”€â”€(SCFAs)â”€â”€â”€> [ Metabolic Gate ]            â”‚
                                    ||                 â”‚
                                    ||         [ â˜ ï¸ Neuronal Loss ]
                                    ||
                             ( BLOOD-BRAIN BARRIER )
```

---

## 2. æ ¸å¿ƒé€»è¾‘ (Core Logic)
è„‘é€€è¡Œæ€§ç–¾ç—…ä¸å†è¢«è§†ä¸ºå•çº¯çš„â€œç¥ç»å…ƒç–¾ç—…â€ï¼Œè€Œè¢«ç†è§£ä¸ºä¸€ç§ **æ…¢æ€§ç¥ç»ç‚ç—‡ (Chronic Neuroinflammation)**ã€‚ç›®å‰çš„ç§‘ç ”èŒƒå¼æ­£ä»â€œæ¶ˆé™¤ç‚ç—‡â€è½¬å‘â€œè°ƒèŠ‚å…ç–«çŠ¶æ€ (Modulating States)â€ã€‚

---

## 3. å…³é”®ç ”ç©¶çº¿ç´¢ (Key Clues)

### A. å¾®èƒ¶è´¨ç»†èƒ (Microglia) çš„åŒå‘æ€§
- **ä¼ ç»Ÿè®¤çŸ¥**ï¼šMicroglia åªæœ‰ M1 (ä¿ƒç‚) ä¸ M2 (æŠ‘ç‚) ä¸¤ç§çŠ¶æ€ã€‚
- **2024-2025 å‘ç°**ï¼šå•ç»†èƒæµ‹åº (scRNA-seq) æ­ç¤ºäº† **DAM (Disease-Associated Microglia)** çš„ç»†åˆ†çŠ¶æ€ã€‚éƒ¨åˆ† DAM åœ¨æ—©æœŸå…¶å®å…·æœ‰ä¿æŠ¤æ€§ï¼ˆè´Ÿè´£åå™¬ AÎ²ï¼‰ï¼Œä½†åœ¨æ™šæœŸåˆ™è½¬å˜ä¸ºç¥ç»æ¯’æ€§ã€‚
- **çº¿ç´¢ (Clue)**ï¼šæ²»ç–—æ—¶æœºæ˜¯å…³é”®ã€‚åœ¨æ—©æœŸæ´»åŒ– DAM å¯èƒ½æœ‰ç›Šï¼Œä½†åœ¨ä¸­æ™šæœŸåˆ™éœ€æŠ‘åˆ¶å…¶ä¿ƒç‚è·¯å¾„ã€‚

### B. T ç»†èƒåœ¨å¤§è„‘ä¸­çš„â€œéæ³•å…¥å¢ƒâ€ä¸ä½œç”¨
- **2025 å‘ç° (Science)**ï¼šç ”ç©¶è¯æ˜åœ¨ AD æ‚£è€…å¤§è„‘çš„â€œç¥ç»å…ç–«ç”Ÿæ€ä½ (Neuro-immune Niche)â€ä¸­å­˜åœ¨å¤§é‡å¤–å‘¨ T ç»†èƒã€‚
- **é€»è¾‘è½¬å‘**ï¼šå¤§è„‘å¹¶éå®Œå…¨çš„â€œå…ç–«ç‰¹æƒåŒº (Immune Privileged)â€ã€‚å¤–å‘¨å…ç–«ç»†èƒçš„æ¸—é€æ˜¯é€€è¡ŒåŠ é€Ÿçš„å…³é”®å› å­ã€‚

---

## 4. æŠ€æœ¯çªç ´ç‚¹ (Technical Edge)
- **Spatial Transcriptomics (ç©ºé—´è½¬å½•ç»„)**ï¼šè®©æˆ‘ä»¬çœ‹æ¸…å…ç–«ç»†èƒæ˜¯åœ¨â€œå“ªé‡Œâ€ä¸ç¥ç»å…ƒå‘ç”Ÿæˆ˜æ–—ï¼Œè€Œéä»…ä»…çŸ¥é“å®ƒä»¬å­˜åœ¨ã€‚

---

## 5. å¾…éªŒè¯å‡è®¾ (Actionable Hypotheses)
- **å‡è®¾ 1**ï¼šé€šè¿‡è°ƒèŠ‚è‚ é“èŒç¾¤äº§ç”Ÿçš„ä»£è°¢ç‰©ï¼Œæ˜¯å¦èƒ½é—´æ¥æ”¹å˜ Microglia çš„è¡¨å‹ï¼Ÿ
- **å‡è®¾ 2**ï¼šé˜»æ–­ç‰¹å®šè¶‹åŒ–å› å­ (Chemokines) é˜»æ­¢ T ç»†èƒè¿›å…¥å¤§è„‘ï¼Œèƒ½å¦å»¶ç¼“è®¤çŸ¥ä¸‹é™ï¼Ÿ

---

## 6. å‚è€ƒæ–‡çŒ® (References)
- **TroulÃ©, K., et al. (2024).** CellPhoneDB v5: inferring cell-cell communication from single-cell multiomics data. *Nature Methods*.
- **Gate, D., et al. (2020/2024 updated).** Clonally expanded CD8 T cells patrol the cerebrospinal fluid in Alzheimer's disease. *Nature*.
- **Zhen, X., et al. (2024).** GSDMD activation is the key molecular mechanism of inflammatory blood-brain barrier disruption. *Nature*.

---
[å›åˆ°ç›®å½•](../README.md)
